Pictet Asset Management Holding Sa Crinetics Pharmaceuticals, Inc. Transaction History
Pictet Asset Management Holding Sa
- $88.9 Billion
- Q4 2024
A detailed history of Pictet Asset Management Holding Sa transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Pictet Asset Management Holding Sa holds 848,050 shares of CRNX stock, worth $28.8 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
848,050
Previous 908,149
6.62%
Holding current value
$28.8 Million
Previous $46.4 Million
6.53%
% of portfolio
0.05%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding CRNX
# of Institutions
255Shares Held
89.5MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$309 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA6.95MShares$236 Million0.07% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$212 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$208 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$184 Million0.03% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.82B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...